Patents by Inventor Byron M. Gallis

Byron M. Gallis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5171675
    Abstract: A macrophage colony stimulating factor, M-CSF.gamma., which is a primary translation product of an alternative mRNA splicing event and is a precursor to biologically active M-CSF. DNA sequences encoding M-CSF.gamma. and recombinant expression vectors comprising the DNA sequences.
    Type: Grant
    Filed: August 8, 1989
    Date of Patent: December 15, 1992
    Inventors: Douglas P. Cerretti, Dirk M. Anderson, Robert J. Tushinski, Byron M. Gallis, David Cosman
  • Patent number: 4923802
    Abstract: A highly specific peptide substrate for protein kinase C is composed in basic form of a serine or threonine amino acid residue flanked by groups of basic amino acids composed entirely of argenine, lysine or histidine or any combination of these amino acid residues. The peptide, which is phosphorylated by the protein kinase C, can be used in a direct or competitive assay for protein kinase C by employing radiolabeled ATP. In the phosphorylation process the phosphate is transferred from the ATP by the protein kinase C to the peptide of the present invention.
    Type: Grant
    Filed: June 13, 1985
    Date of Patent: May 8, 1990
    Assignee: Immunex Corporation
    Inventor: Byron M. Gallis